Human medicines European public assessment report (EPAR): Capecitabine Accord, capecitabine, Date of authorisation: 20/04/2012, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): NeoRecormon, epoetin beta, Date of authorisation: 16/07/1997, Revision: 35, Status: Authorised

Emergency Task Force (ETF) documents

PRAC-ETF considerations on the use of Ixchiq live attenuated virus vaccine against chikungunya

Organisation chart: Advisory functions

Human medicines European public assessment report (EPAR): Capecitabine Medac, capecitabine, Date of authorisation: 19/11/2012, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Xeloda, capecitabine, Date of authorisation: 02/02/2001, Revision: 31, Status: Authorised

Human medicines European public assessment report (EPAR): Eptifibatide Accord, eptifibatide, Date of authorisation: 11/01/2016, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Levetiracetam Sun, levetiracetam, Date of authorisation: 14/12/2011, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR): Fintepla, fenfluramine, Date of authorisation: 18/12/2020, Revision: 12, Status: Authorised